X-65716908-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002444.3(MSN):c.96+7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000537 in 1,201,022 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 189 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002444.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSN | NM_002444.3 | c.96+7C>T | splice_region_variant, intron_variant | ENST00000360270.7 | NP_002435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSN | ENST00000360270.7 | c.96+7C>T | splice_region_variant, intron_variant | 1 | NM_002444.3 | ENSP00000353408.5 |
Frequencies
GnomAD3 genomes AF: 0.000400 AC: 44AN: 109920Hom.: 0 Cov.: 22 AF XY: 0.000373 AC XY: 12AN XY: 32160
GnomAD3 exomes AF: 0.000274 AC: 50AN: 182588Hom.: 0 AF XY: 0.000238 AC XY: 16AN XY: 67186
GnomAD4 exome AF: 0.000551 AC: 601AN: 1091102Hom.: 0 Cov.: 28 AF XY: 0.000496 AC XY: 177AN XY: 356618
GnomAD4 genome AF: 0.000400 AC: 44AN: 109920Hom.: 0 Cov.: 22 AF XY: 0.000373 AC XY: 12AN XY: 32160
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2022 | MSN: BP4, BS2 - |
MSN-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 12, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at